Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
NCT06765278

Anterior Glenoid Nerve Block Versus Pericapsular Nerve Group Block Versus Interscalene Brachial Plexus Block for Postoperative Pain Management in Shoulder Arthroscopic Surgeries

Led by Ain Shams University · Updated on 2025-01-14

49

Participants Needed

1

Research Sites

19 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims to compare between Anterior glenoid nerve block, pericapsular nerve group (PENG) block and Interscalene brachial plexus (ISB) block for post-operative pain management in shoulder arthroscopic surgeries

CONDITIONS

Official Title

Anterior Glenoid Nerve Block Versus Pericapsular Nerve Group Block Versus Interscalene Brachial Plexus Block for Postoperative Pain Management in Shoulder Arthroscopic Surgeries

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age from 18 to 70 years
  • No sex predilection
  • American Society of Anesthesiology (ASA) physical status I-II
  • Undergoing shoulder arthroscopic surgeries
Not Eligible

You will not qualify if you...

  • Patient's refusal
  • History of drug allergies to study drugs
  • Local infection at the injection site
  • Inability to cooperate
  • Neuromuscular pathology such as Multiple Sclerosis
  • Previous trauma or surgery to the shoulder

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Ain Shams University

Cairo, Egypt, 11591

Actively Recruiting

Loading map...

Research Team

M

Mohamed Serry, Master

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here